# RiverVest Ventures

RiverVest Ventures is a Venture Capital based in St. Louis, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** St. Louis, United States
- **Region:** North America
- **Address:** St. Louis, MO, United States
- **Founded:** 2000
- **Assets under management:** Undisclosed
- **Website:** www.rivervest.com
- **LinkedIn:** https://www.linkedin.com/company/rivervest-venture-partners

## Regulatory record

- **Reports private funds:** No

## About

RiverVest Venture Partners is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong results to investors. Founded in St. Louis in September 2000, the firm invests in biopharma and medical devices. It has headquarters in St. Louis and offices in San Diego and Cleveland.

## Sectors

- Biopharma
- Medical Devices

## Offices

- San Diego, CA
- Cleveland, OH

## People

- Jay W. Schmelter — Co-Founder & Managing Director
- Tom Melzer — Co-Founder and Managing Director
- Niall O'Donnell — Managing Director
- Derek Rapp — Managing Director
- Karen Spilizewski — Managing Director
- Isaac Zike — Managing Director
- John McKearn — Senior Advisor
- Pascal Krotee — Principal
- Nafise Masoumi — Principal
- Michael Berman — Consultant and Venture Partner

## Questions

### Who runs investment decisions at RiverVest?

Investment decisions are made by a partnership group that includes co-founders Jay Schmelter and Tom Melzer alongside managing directors Niall O’Donnell, Derek Rapp, Karen Spilizewski, and Isaac Zike. Schmelter, a co-founder of portfolio company Salient Surgical, has been with the firm since its 2000 launch and remains the most visible deal lead. The firm describes a team-based approach to decision-making, with managing directors sharing oversight of portfolio companies.

### How does RiverVest source its deal flow?

RiverVest sources opportunities through offices in St. Louis, San Diego, and Cleveland, each positioned near major research universities and clinical centers. The firm states it partners with a network of entrepreneurs, investors, and key opinion leaders, and it also accesses deal flow through its scientific advisors, who include faculty at the University of Colorado, UCLA, and the La Jolla Institute for Immunology.

### Does RiverVest invest in platform technologies or product-focused companies?

The firm explicitly invests in products with a known path to clinical approval rather than platform technologies. It places emphasis on demonstrating safety and efficacy in early clinical trials, and it targets areas where large pharmaceutical or medical-device companies have pipeline needs.

### What investment stages does RiverVest target?

RiverVest invests from seed through late-stage, with a particular focus on founding and leading early-stage rounds. The firm also operates the Archer Seed Fund for very-early-stage companies and the 3×5 Special Opportunity Fund, a joint venture with Arnerich Massena, for concentrated later-stage life-science and natural-resource positions.

### Which portfolio companies have produced notable exits for RiverVest?

Lumena Pharmaceuticals, co-founded and seed-funded by RiverVest, was acquired by Shire in a deal that returned roughly $400 million to investors. Allakos went public in 2018 in one of the year's most successful biotech IPOs and later delivered a 9x return. Lutonix returned 8.0x gross, and both Good Therapeutics (acquired by Roche) and Standard Bariatrics (acquired by Teleflex) closed on the same day in 2022.

### What is RiverVest's geographic footprint, and why does it matter?

The firm operates from St. Louis, San Diego, and Cleveland. This three-city model gives it access to research universities and clinical centers in the Midwest, Southern California, and the Great Lakes region — a sourcing network that is structurally different from the single-hub model used by most life-science venture firms.

## Related profiles

- [River Venture Partners](https://altss.com/profile/river-venture-partners)
- [Riverview Research](https://altss.com/profile/riverview-research)

---

Last updated: 2026-08-11T15:07:57.118Z

Canonical page: https://altss.com/profile/rivervest-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology